Stock search

Ticker or company name

Compare stocks

Market: US

  • BIIBBiogen

Add stock

Ticker or company

Summary

BIIB
Biogen
$251,65Down −0,69%
Year: Up +54%
31/100Ratio would not consider buying
Open stock page

Traffic light — 10 checks

CheckBIIB1 ✓ 3 — 4 ✕
P/E vs its history107,8
P/E vs industry107,8
Forward P/E16,5
Revenue growth, YoY+2,3%
EPS growth, YoY−78,9%
Net margin3,4%
Net debt / EBITDAn/a—
Free cash flow$2,07 bn
Share count over a year+0,5%
Cash runwayn/anot needed

Metrics

Best WorstNo mark — in between

Metric · betterBIIBTTMIndustry medianTTM
P/E TTM ↓107,842,1
Forward P/E ↓16,518,7
PEG ↓22,44,1
P/S TTM ↓3,66,6
EV/EBITDA ↓36,228,2
P/FCF ↓22,126,0

Price, %

  • BIIBn/a

Returns

Best WorstNo mark — in between

PeriodBIIB
1 yearn/a
3 yearsn/a
5 yearsn/a
All timen/a

“Per year” is the average annual return: 90% growth over 3 years is 23,9% per year, not 30%. “All time” starts at the IPO, so only “per year” compares fairly. Prices adjusted for splits, dividends reinvested.

Analysts and insiders

Best WorstNo mark — in between

BIIB
Share of “buy”73%
Beat the forecast4 of 4
Average “surprise”+24,0%
Insiders over 12 monthssales $904 829

Details are on each stock page.